Abstract
BackgroundGrowing evidence suggests that SALL4 plays a vital role in tumor progression and metastasis. However, the molecular mechanism of SALL4 promoting esophageal squamous cell carcinoma (ESCC) remains to be elucidated.MethodsThe gene and protein expression profiles- were examined by using quantitative real-time PCR, immunohistochemistry and western blotting. Small hairpin RNA was used to evaluate the role of SALL4 both in cell lines and in animal models. Cell proliferation, apoptosis and invasion were assessed by CCK8, flow cytometry and transwell-matrigel assays. Sphere formation assay was used for cancer stem cell derivation and characterization.ResultsOur study showed that the transcription factor SALL4 was overexpressed in a majority of human ESCC tissues and closely correlated with a poor outcome. We established the lentiviral system using short hairpin RNA to knockdown SALL4 in TE7 and EC109 cells. Silencing of SALL4 inhibited the cell proliferation, induced apoptosis and the G1 phase arrest in cell cycle, decreased the ability of migration/invasion, clonogenicity and stemness in vitro. Besides, down-regulation of SALL4 enhanced the ESCC cells’ sensitivity to cisplatin. Xenograft tumor models showed that silencing of SALL4 decreased the ability to form tumors in vivo. Furthermore, our study demonstrated that SALL4 played a vital role in modulating the stemness of ESCC cells via Wnt/β-catenin signaling pathway and in epithelial-mesenchymal transition.ConclusionsOur results revealed that SALL4 might serve as a functional marker for ESCC cancer stem cell, a crucial marker for prognosis and an attractive candidate for target therapy of ESCC.
Highlights
Growing evidence suggests that sal-like protein 4 (SALL4) plays a vital role in tumor progression and metastasis
The level of SALL4 expression is up-regulated in Esophageal squamous cell carcinoma (ESCC) tissues To investigate the expression of SALL4 in ESCC, one hundred and thirty-three paired ESCC tissues and adjacent non-cancerous tissues were analyzed by real-time polymerase chain reaction (PCR)
The results showed that SALL4 expression in ESCC tissues was significantly higher than that in the matched noncancerous tissues (P < 0.0001, Fig. 1a and b)
Summary
Growing evidence suggests that SALL4 plays a vital role in tumor progression and metastasis. The molecular mechanism of SALL4 promoting esophageal squamous cell carcinoma (ESCC) remains to be elucidated. Esophageal cancer is the sixth leading cause of cancerrelated death in the world and third in China [1, 2]. Esophageal squamous cell carcinoma (ESCC) is the predominant subtype of esophagus cancer. CSCs were widely studied in various tumors and CSCs targeted therapy could be a great help for ESCC treatment [6]. CSCs have high tumor-initiating, self-renewal and differentiation ability. CSCs are resistant to chemotherapy and radiotherapy and responsible for cancer recurrence and distant metastasis [7, 8]. Markers that identify CSCs have been found in some tumors [9, 10].
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Experimental & Clinical Cancer Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
